Notably, USP22 was initially reported as a member of an 11-gene “death from cancer” gene expression signature which identified tumors displaying a stem cell-like gene expression profile characterized by high malignancy and metastatic dissemination [27]. The gene discussed is USP22; the disease is cancer.